DCM
GWPH

Delpha Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Delpha Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-630
Closed -$83K – 1476
2017
Q4 		$83K Buy
+630
New +$74K 0.09% 172

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Delpha Capital Management's GWPH Position: Q1 2018 in Review

Delpha Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2018, closing a stake of 630 shares — an estimated $83K sold.

Delpha Capital Management first reported a position in GWPH in Q4 2017 and held it in 1 quarter. The position peaked at $83K in Q4 2017. 191 funds tracked by Wall St. Rank hold GWPH as of Q1 2018.

  • Delpha Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 630 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2018, an estimated $83K.
  • Delpha Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $83K in Q4 2017.
  • 191 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.